Conference Recordings

Conference Sessions

 
Picture of the product2016 Conference Recordings - Full Conference Sessions
Complete set of session recordings (not including Preconference Courses) from the 2016 International Conference held 10-13 July 2016.

Non-Member price: $300.00
Discounted Member price: $170.00
Quantity    

 View Cart
W_AM16_FULL
Picture of the productISPD 2016: Debate 1 - In Utero Therapy for Spina Bifida

Plenary Debate 1- In Utero Therapy for Spina Bifida is Ready for Endoscopic Repair: 1 hour, 11 minutes

For: Michael Belfort (USA) ** NOT SHARED IN THIS RECORDING.
Against: Jan Deprest (Belgium)

Fetal therapy: In Utero Therapy for Spina Bifida is ready for endoscopic repair.


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_D1
Picture of the productISPD 2016: Debate 2 - Using cfDNA Maternal Serum Biomakers

Plenary Debate 2 - For Those Women Screened by NIPT Using Cell Free DNA Maternal Serum Biomarkers Are Obsolete: 1 hour, 20 minutes

For: Yuval Yaron (Israel)
Against: Jon Hyett (Australia)

In numerous studies, NIPT has been proven to be the most effective screening method for fetal aneuploidy, far surpassing any combination of ultrasound and biochemical markers. The efficacy of biochemical markers for the early detection of pregnancy complications is limited and does not warrant their use in the general population that has received NIPT screening.


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_D2
Picture of the productISPD 2016: Debate 3 - Industry Drives Innovation

Plenary Debate 3 - Industry Drives Innovation in Research and Clinical Application of Genetic Prenatal Diagnosis and Screening: 55 minutes

For: Tom Musci (USA)**NOT SHARED IN THIS RECORDING.
Against: Joris Vermeesch (Belgium)

A debate on industry drives innovation in research and clinical application of genetic prenatal diagnosis and screening.


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_D3
Picture of the productISPD 2016: Plenary-Top Late Breaking Abstracts

Plenary: Late Breaking Abstracts: 1 hour, 45 minutes

LB-1 Chromosomal aberrations other than the common trisomies detected by non-invasive prenatal testing (NIPT): Cytogenetic and clinical follow-up investigations during and after pregnancy, Diane Van Opstal (Netherlands)
LB-2 Early ovarian cancer detection in non pregnant women using a clinical non-invasive prenatal testing platform: Implications for cancer screening, Lisa Hui (Australia)
LB-3 Prenatal Transplantation of Human Amniotic Fluid Stem Cells Could Improve the Clinical Outcome of Type III Spinal Muscular Atrophy, S.W. Steven Shaw (Taiwan)
MALCOLM FERGUSON-SMITH AWARD PRESENTATION, Dr. Suzanne Drury, Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities (UK)**
Diana Bianchi (USA), NIPT using cfDNA beyond aneuploidy: What should we be doing?
Michael Parker (UK): Ethical aspects in the new era of genomic medicine with more comprehensive testing and easier access to prenatal testing

**NOT SHARED IN THIS RECORDING.


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_P2
Picture of the productISPD 2016: Plenary - Top Abstracts, Joe Leigh Simpson Award

Plenary-Top Abstracts, Joe Leigh Simpson Award: 59 minutes

T-1 The effect of a decision aid on informed decision making in the era of non-invasive prenatal testing: A randomised controlled trial, Lean Beulen**
T-2 An integrated human/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome, Faycal Guedj
T-3 Amniotic fluid transcriptomic changes in fetuses with myelomeningocele, Tomo Tarui
T-4 A bespoke non-invasive prenatal diagnostic (NIPD) Service for paternal Mutation and de novo Recurrence Exclusion, Lucy Jenkins**
T-5 Genomes and Pregnancy, the GaP Study: Providing Choice of Fetal Genomic Results to Women having Prenatal Diagnosis, Jane Halliday

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_P1
Picture of the productISPD 2016: Session 1 - Testing for Single Gene Disorders

Session 1 - Testing for Single Gene Disorders: 1 hour, 11 minutes
Matt Hurles (UK), Challenges in interpretation and application of whole exome sequencing for prenatal diagnosis: Does the postnatal experience help us?**
Ignatia Van den Veyver (USA), How should we approach prenatal counselling to account for VUS and secondary findings?
1-2 The Utility of Whole Exome Sequencing in Prenatal Diagnosis, Magdalena Walkiewicz (USA)
1-3 Validation of Non-invasive prenatal diagnosis (NIPD) of multiple single gene disorders for clinical implementation, Stephanie Allen (UK)
1-4 Non-invasive prenatal diagnosis (NIPD) for Cystic Fibrosis Beyond paternal mutation exclusion, Suzanne Drury** (UK)
1-5 Haplotype-assisted noninvasive prenatal diagnosis of common monogenic diseases using massively parallel sequencing of plasma cell-free DNA ,Ya Gao (China)

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S1
Picture of the productISPD 2016: Session 2 - Fetal Therapy

Session 2 - Fetal Therapy: 2 hours, 5 minutes

Greg Ryan (Canada), Fetal therapy: The state of the art
Wybo Dondorp (Netherlands), Ethical principles of fetal therapy
Enrico Lopriore (Netherlands), Longterm outcome after fetal therapy
Tim Van Mieghem (Belgium), Maternal complications of fetal therapy
2-1 Expansion of assessment methods to measure effects of fetal spina bifida induction and repair in the fetal lamb, Luc Joyeux (Belgium)
2-2 Connexin 43 is overexpressed in human fetal membrane defects after fetoscopic surgery, David Barrett (UK)
2-3 BOOSTB4 A clinical study on pre- and/or postnatal stem cells transplantation for treatment of osteogenesis imperfecta, Anna David (UK)


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S2
Picture of the productISPD 2016: Session 3 - Molecular Approaches to PDx

Session 3 - Molecular Approaches to Prenatal Diagnosis: 28 minutes

Ron Wapner (USA), Array CGH as first line testing for ultrasound anomalies**
Francesca Romana Grati (Italy), Mosaicism and its implications for prenatal diagnosis
3-1 External quality assessment of testing cell free DNA for fetal sex determination, Zandra Deans (Sandi) (UK)
3-2 Realization of the Belgian Prenatal Microarray (BEMAPRE) database and update of the Belgian reporting approach, Joke Muys (Belgium)**
3-3 Maternal cell contamination may significantly confound the interpretation of prenatal NGS testing, Zena Wolf (USA)**

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S3
Picture of the productISPD 2016: Session 4 - First Trimester Ultrasound

Session 4 - First Trimester Ultrasound: 58 minutes

Karl Oliver Kagan (Germany), Screening for aneuploidy other than DS using combined testing and fetal anomaly scanning in the first trimester
Rabih Chaoui (Germany), First trimester ultrasound for non-aneuploid genetic syndromes
4-1 Chromosomal microarray analysis in foetuses with aberrant right subclavian artery, Idit Maya (Israel)**
4-2 Early sonographic evaluation of facial integrity in dystrophic fetuses via 3D-ultrasound, David Hartge (Germany)**
4-3 Antral follicle size as a first trimester predictor of fetal trisomy, Janisse Ferreri (Spain)**

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S4
Picture of the productISPD 2016: Session 5 - Moving Earlier

Session 5 - Moving Earlier: 2 hours, 20 minutes

Katerina Vesela (Czech Republic), Implementing PGD and PGS in clinical practice
Martina Cornel (Netherlands), Preconception and carrier screening: The big picture
5-1 International Variability in 47,XXY (Klinefelter Syndrome) Phenotype, Carole Samango-Sprouse (USA)
5-2 A Large Prospective Study of the Neurodevelopmental Outcome in Prenatally Diagnosed Males with 47, XXY, Carole Samango-Sprouse (USA)
5-3 Randomized controlled trial comparing preimplantation genetic screening utilizing next generation sequencing to standard morphologic assessment for embryo selection and single embryo transfer after vitrification, Saba Parsa (USA)
5-4 Clinical experience with multigene carrier panels, Catherine Terhaar (USA)
5-5 Aneuploidy screening in polarbodies is superior to trophectoderm analysis as it detects the meiotic errors and circumvents decision making of mosaic embryo results, Angelika Daser (Germany)
5-6 The timing of reproductive genetic counseling is the most important factor influencing acceptance of expanded carrier screening, Ignatia Van den Veyver (USA)


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S5
Picture of the productISPD 2016: Session 6 - Adverse Pregnancy Outcomes

Session 6 - Adverse Pregnancy Outcomes: 1 hour, 26 minutes

Anna David (UK), Current and future approached to the prevention and treatment of IUGR
Stefan Verlohren (Germany), Clinical implementation of the sFLIT:PLGF ratio and other maternal serum biomarkers for the prediction of adverse pregnancy outcomes**
6-1 Confined placental mosaicism: re-evaluation of pregnancy characteristics and influence on fetal growth, Jérôme Toutain (France)
6-2 The development of a placental murine xenograft model, Magali Verheecke (Belgium)**
*LB-22 An international registry for women exposed to Zika virus during pregnancy: Time for answers, David Baud (Switzerland)
6-4 Increased risk for pregnancy loss, true fetal mosaicism and uniparental disomy associated with rare autosomal aneuploidies identified during non-invasive prenatal testing, Mark D Pertile (Australia)
6-5 Incremetal yield of Genomic Microarray in Early Growth Restricted Fetuses Over Karyotyping, Antoni Borrell (Spain)
6-6 Discordant hypoxic condition and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction, Yu Gao (China)

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S6
Picture of the productISPD 2016: Session 7 - NIPT Current Issues

Session 7 - NIPT Current Issues: 45 minutes

Arthur Beaudet (USA), Will fetal cells have a place in prenatal diagnosis?
Jane Fisher (UK), The good the bad and the ugly stakeholder perceptions of NIPT for aneuploidy
7-1 Clinical implementation of NIPT: Understanding the role of non-specialist provider education, Subhashini Chandrasekharan (USA)**
7-2 Ensuring high quality NIPD and NIPT for the patient, Zandra Deans (Sandi) (UK)**
7-3 Odds of being affected given a positive result (OAPR) in cell-free DNA screening for fetal autosomal and sex chromosome aneuploidy: Data from four cytogenetic laboratories, Danielle LaGrave (USA)
7-4 Fetal aneuploidy screening results in maternal plasma samples redrawn due to insufficient fetal cfDNA in the initial sample, Maximillian Schmid (USA)**
7-5 Decisional regret in women receiving high-risk or inconclusive results from non-invasive prenatal genetic screening, Megan Allyse (USA)**
7-6 Plasma DNA tissue mapping to pinpoint site of occult maternal malignancy identified by NIPT, Rossa Chiu (Hong Kong)**

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S7
Picture of the productISPD 2016: Session 8 - Innovative Imaging

Session 8 - Innovative Imaging: 45 minutes

Gregor Kasprian (Austria), Fetal MRI for detailed evaluation of cerebral structure and function**
Owen Arthurs (UK), Postmortem imaging: Decline of the histopathologist?**
8-2 Head circumference of fetuses with congenital heart disease decreases in the second half of pregnancy, Ilse Haveman (Netherlands)
8-3 Fetal neuronal migration disorder between 15 and 26 weeks of gestation, Ritsuko Pooh (Japan)**
8-4 Diagnostic accuracy of congenital heart defects after referral from routine ultrasound screening, Ilse Haveman (Netherlands)
8-5 From foetal dysmorphology to exome sequencing: The diagnostic performance for making a perinatal genetic diagnosis, Shagun Aggarwal (India)

**NOT SHARED IN THIS RECORDING


Non-Member price: $50.00
Discounted Member price: $20.00
Quantity    

 View Cart
W_AM16_S8

No content found

No content found

No content found